Results 171 to 180 of about 25,904 (219)
Some of the next articles are maybe not open access.
The Bradykinin B2-Receptor in Human Decidua
Seminars in Thrombosis and Hemostasis, 1999Bacterial infection of the amniotic cavity is one of the most frequent causes of preterm delivery. Bacterial products activate a network of autocrine and paracrine mediators in fetal membranes and decidua, with prostaglandins finally inducing contractions of the myometrium. Bradykinin and its B2-receptor (B2R) seem to be part of this network.
P, Buchinger, J, Rehbock
openaire +2 more sources
Bradykinin receptor types and B2 subtypes
Life Sciences, 1994Bradykinin, desArg9BK, some agonist analogues and several antagonists have been tested in isolated organs in order to identify bradykinin B2 receptor subtypes. The initial pharmacological characterization was made in the rabbit jugular vein and the guinea pig ileum, two widely used B2 preparations which have shown marked differences in their ...
D, Regoli +6 more
openaire +2 more sources
Activation of B2 bradykinin receptors by neurotensin
Cellular Signalling, 2003Many previous reports suggested that relatively high concentrations of neurotensin were required to exert its effects on neurotransmitter secretion. The neurotensin binding sites, which recognize high concentrations of neurotensin, were characterized in rat pheochromocytoma (PC12) cells. When PC12 cells were treated with neurotensin, [3H]norepinephrine
Park, TJ, Kim, KT
openaire +3 more sources
Bradykinin receptors in isolated rat duodenum
Peptides, 1990Pharmacological properties of the bradykinin receptors in the isolated rat duodenum were investigated by examining the relaxant and contractile responses to bradykinin and [des-Arg9]-bradykinin, an agonist of B1 receptors. A specific desensitization and de novo formation for B1 receptors were observed.
Altınkurt, Onur, Öztürk, Yusuf
openaire +2 more sources
Bradykinin receptor ligands: therapeutic perspectives
Nature Reviews Drug Discovery, 2004Kinins, which are produced by the action of kallikrein enzymes, are blood-derived local-acting peptides that have broad effects mediated by two related G-protein-coupled receptors termed the bradykinin receptors. The endogenous kallikrein-kinin system controls blood circulation and kidney function, and promotes inflammation and pain in pathological ...
François, Marceau, Domenico, Regoli
openaire +2 more sources
Expression and function of bradykinin receptors in microglia
Life Sciences, 2003Expression of bradykinin (BK) receptors and their cellular function were investigated in microglia. Microglial cells were isolated from mixed cultures of cerebrocortical cells from postnatal day 3 Wistar rats. Reverse transcription-PCR (RT-PCR) showed that rat primary microglia express mRNAs for the type 2 bradykinin (B(2)) receptor subtype but not the
Mami, Noda +6 more
openaire +2 more sources
Intracellular and nuclear bradykinin B2 receptors
European Journal of Pharmacology, 2014Bradykinin is a vasoactive peptide that participates in numerous inflammatory processes, vasodilation, and cell growth/survival; it mainly acts through two receptor subtypes, bradykinin B1 and bradykinin B2 receptors, which are G protein-coupled receptor (GPCR) family members.
Masaoki Takano, Shogo Matsuyama
openaire +2 more sources
Characterization of bradykinin receptors in peripheral organs
Canadian Journal of Physiology and Pharmacology, 1991Bradykinin (BK) and related kinins are potent stimulants of the rabbit jugular vein, the hamster urinary bladder, and the guinea pig trachea. The characterization of kinin receptors in these tissues was made with agonists and antagonists. Results obtained with agonists indicate that bradykinin and kallidin are much more active than des-Arg9-BK and ...
N E, Rhaleb +4 more
openaire +2 more sources
Journal of Medicinal Chemistry, 2012
The bradykinin (BK) B1 receptor is an attractive target for the treatment of chronic pain and inflammation. Starting from a dual B1 and B2 antagonist, novel antagonists were designed that display low-nanomolar affinity for human B1 receptor and selectivity over B2.
Martine, Barth +7 more
openaire +2 more sources
The bradykinin (BK) B1 receptor is an attractive target for the treatment of chronic pain and inflammation. Starting from a dual B1 and B2 antagonist, novel antagonists were designed that display low-nanomolar affinity for human B1 receptor and selectivity over B2.
Martine, Barth +7 more
openaire +2 more sources